1. Home
  2. Browse
  3. HRA003964
HRA003964
   HRA003964.xlsx
Title:
KK-LC-1 represents a feasible therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer
Release date:
2023-03-31
Description:
One of the objectives of this study was to explore the differential expression genes in triple-negative breast cancer after resistance to docetaxel.
Data Accessibility:   
Controlled access Request Data
BioProject:
PRJCA012088
Study type:
Cell line related study
Disease name:
triple-receptor negative breast cancer
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
HDAC002281
DAC name:
CSC&TM DAC
Contact person:
Liu Caigang
Email:
liucg@sj-hospital.org
Description:
Our Data Access Communitee consists of two members whose main responsibilities are to oversee and supervise the work of the Data Governance Office and to adjudicate interdepartmental coordination issues that may arise in the data governance process and that the Data Governance Office cannot resolve.
Individuals & samples
Files
Request Data
Submitter:   Liu Caigang / liucg@sj-hospital.org
Organization:   Shengjing Hospital of China Medical University
Submission date:   2023-02-15
Requests:   -